First PCSK9 Inhibitor Gets FDA Approval for MI, Stroke Prevention First PCSK9 Inhibitor Gets FDA Approval for MI, Stroke Prevention Monthly Prescribing Reference Amgen’s PCSK9 Inhibitor Gets FDA Nod for Stroke Prevention Nasdaq FDA approves evolocumab to prevent heart attack and stroke Cardiovascular Business Full coverage 5 DIC 0
